Center Book Partners LP Atri Cure, Inc. Transaction History

Center Book Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$32.99 - $43.25 $380,506 - $498,845	-11,534 Reduced 65.58%	6,055 $216,000
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $723,259 - $1.02 Million	17,589 New	17,589 $770,000
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $380,473 - $500,862	-10,607 Reduced 67.13%	5,193 $215,000
Q4 2022 Feb 13, 2023	BUY	$33.48 - $47.45 $298,407 - $422,921	8,913 Added 129.42%	15,800 $701,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $263,427 - $362,393	6,887 New	6,887 $269,000

212

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.85B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

Stay updated on Center Book Partners LP with notifications on news.